Complete Conference Management 9th Annual Symposium Contemporary Management of Cardiovascular Disease in Women 2026

Cardiovascular Disease in Women 2026

Cardiovascular Disease in Women | Women’s Heart Health | Sex-Specific Cardiovascular Risk | Preventive Cardiology | Patient-Centered Cardiovascular Care

The Complete Conference Management 9th Annual Symposium Contemporary Management of Cardiovascular Disease in Women 2026 provides an evidence-based review of cardiovascular prevention, diagnosis, and treatment in women. The program emphasizes how sex-specific risk factors, clinical presentations, and differences in care can influence cardiovascular assessment and management.

Through expert presentations, case-based discussions, and practical clinical applications, the symposium connects emerging evidence with everyday patient care. Its educational focus extends beyond recognizing cardiovascular disease to improving risk assessment, supporting earlier diagnosis, addressing disparities, and developing individualized treatment strategies for women across their lifespan. Women’s CV DLA

Course Details

The organizer confirms the symposium’s edition, date, and venue; the registration information identifies the original activity as a hybrid event. CCM Meetings

Target Audience

This program has been designed to provide primary care physicians, internists, cardiologists, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare providers with the necessary information to increase knowledge and awareness of cardiovascular disease in women with the goal of improving patient care. Women’s CV DLA

Program Overview

The symposium brings together prevention, diagnostic assessment, pharmacological treatment, and cardiovascular interventions within a women-focused clinical framework.

Its scope includes cardiovascular risk assessment, lipid management, hormonal considerations, heart failure, atrial fibrillation, cardiomyopathies, and structural heart disease. The program also examines cardiovascular–kidney–metabolic disease and uses clinical cases to explore treatment decisions involving coronary disease and advanced interventions.

This combination connects the work of primary care clinicians and cardiovascular specialists, emphasizing the recognition of sex-specific differences without separating those considerations from the broader management of cardiovascular disease. Women’s CV DLA

Main Objective

The objective of this symposium is to educate healthcare providers on gender-specific approaches in prevention, diagnosis, and treatment of women with a broad range of cardiovascular diseases. Women’s CV DLA

Learning Objectives

By the end of the symposium participants will be able to:

1. Identify sex-specific risk factors and clinical presentations associated with cardiovascular disease in women.
2. Apply current evidence-based guidelines for the prevention, diagnosis, and management of cardiovascular disease in women across their lifespan.
3. Develop patient-centered strategies to improve cardiovascular risk assessment, education, and outcomes for women in diverse clinical settings. Women’s CV DLA

Needs Assessment

Cardiovascular disease (CVD) is the leading cause of death among women, yet it continues to be under-recognized, under-diagnosed, and under-treated. Women often present with atypical symptoms and have unique risk factors related to pregnancy, menopause, autoimmune disorders, and hormonal changes that may delay diagnosis and treatment. Healthcare professionals require updated knowledge on sex-specific cardiovascular risk assessment, evidence-based prevention strategies, and current treatment guidelines to improve early recognition, reduce disparities in care, and optimize outcomes for women with cardiovascular disease. Women’s CV DLA

Official Program Coverage

The following tables summarize the organizer’s scheduled topics rather than reproduce the lecture titles verbatim. They are not a verified inventory of the MedicalAmboss recordings. Full faculty names appear below.

Morning Program

These topics appear in the organizer’s morning agenda. Women’s CV DLA

Afternoon Program

Four Q&A periods and opening/closing remarks complement the lectures. Women’s CV DLA

Separately Identified Non-CME Product Theatres

The organizer labels both product theatres Non-CME. Women’s CV DLA

Major Topics Covered

The principal educational themes are women’s cardiovascular risk assessment, preventive cardiology, lipid management, hormone-related cardiovascular considerations, heart failure, arrhythmias, cardiomyopathies, structural heart disease, coronary interventions, and cardiovascular–kidney–metabolic health.

Across these areas, the program emphasizes the relationship between sex-specific clinical differences, treatment selection, and equitable cardiovascular care. Women’s CV DLA

Course Director

Christina Economides, MD, MM, FSCAI

The official faculty page identifies Dr. Economides as Program Director and lists her leadership of the STEMI Receiving Center and Women’s Cardiovascular Health Program at PIH Health Good Samaritan Hospital, Los Angeles. Women’s CV DLA

Faculty

These names and affiliations are listed in the symposium’s official faculty directory. Women’s CV DLA

Why This Course Is Relevant

For primary care clinicians and internists, the symposium connects cardiovascular risk assessment with the recognition of clinical presentations that may otherwise be overlooked. Its patient-centered objectives emphasize prevention, education, and the coordination of care.

For cardiologists and multidisciplinary cardiovascular teams, the program places women-specific considerations within a broad diagnostic and therapeutic framework. The educational emphasis is on applying evidence while remaining attentive to differences in presentation, individual risk, and access to appropriate treatment.

For nurses, advanced practice providers, and pharmacists, its focus on risk recognition, patient education, and collaborative management aligns with the needs of teams caring for women in diverse clinical settings. These applications reflect the course’s stated audience and educational objectives. Women’s CV DLA

Original Activity Accreditation

The original symposium was approved for up to 6.5 Live AAFP Prescribed credits, with approval covering September 26, 2026. That accreditation applies to eligible participation in the organizer’s activity; it does not establish that separately purchased MedicalAmboss materials include CME credit or a certificate. Women’s CV DLA

Related Learning on MedicalAmboss

For additional women-focused cardiovascular education, explore Houston Methodist Heart of a Woman: Strategies for Treating and Preventing Heart Disease in Women 2026 and Scripps 5th Annual Scripps Arrhythmias and Cardiomyopathy in Women Symposium 2025

+ Topics: